Eli Lilly & Co
LLY· NYSE
Released Feb 3, 2022, before the open
10-K filed Feb 23, 2022, 54 days after period end · 0000059478-22-000068
derived · Computed from the longer spans the company filed.
| Metric | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019 | Q4 2018 |
|---|---|---|---|---|
| Revenue | $8.00B | $7.44B | $6.11B | $5.64B |
| Net Income | $1.73B | $2.12B | $1.50B |
Eli Lilly & Co · CIK 59478 · Engraved from SEC EDGAR
| $1.13B |
| EPS Diluted | — | — | $1.64 | $1.10 |
|---|
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.